Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 6.57M | $124.0M | 0.59% | -- | 2026-06-30 |
| TCG Crossover Management, LLC | 6.14M | $116.0M | 0.55% | -- | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 5.74M | $109.0M | 0.51% | +36.3K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 3.37M | $64.0M | 0.30% | +1.94M | 2026-06-30 |
| FMR LLC | 2.82M | $53.0M | 0.25% | +1.55M | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 2.32M | $43.0M | 0.21% | +2.20M | 2026-06-30 |
| Woodline Partners LP | 2.21M | $41.0M | 0.20% | +2.01M | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 1.90M | $36.0M | 0.17% | -- | 2026-06-30 |
| BAMCO INC /NY/ | 1.62M | $30.0M | 0.14% | -34.6K | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.33M | $25.0M | 0.12% | -386.9K | 2026-06-30 |
